A/Prof Rebecca Lim ranked top applicant for strong industry collaborations

15 March 2019
Congratulations A/Prof Rebecca Lim, here with Prof Sharon Lewin and Prof Anne Kelso (L-R)
Associate Professor Rebecca Lim from the Hudson Institute of Medical Research was ranked the highest applicant in the industry category for the 2018 National Health and Medical Research Council (NHMRC) Career Development Fellowship Scheme.

The award is given to the highest ranked applicant in the biomedical, clinical, industry and population health pillars of the scheme of which she was awarded in the industry category.

NHMRC chief executive officer, Professor Anne Kelso, presented the award to A/Prof Lim at the NHMRC Council dinner on Wednesday 13 March in Canberra.

A/Prof Lim has dedicated her research to understanding how stem cells from the amniotic sac could change the progression of life-threatening diseases. 

A/Prof Lim’s major focus is to work with industry and clinical collaborators to translate regenerative medicine to effective treatments. Her aim is to introduce innovative technologies that will advance regulatory approval of regenerative medicines in a safe, effective manner.

By working with industry partners, A/Prof Lim hopes to increase patient access to safe and affordable cellular therapies.

Moreover, A/Prof Lim hopes that this award will see more young scientists seeking opportunities to engage with industry, government and patient advocacy groups. She encourages them to venture beyond the walls of academia to translate their discoveries and maximise impact. “Seeking out mentors from industry and clinical practice will provide you with unique insights into making your discovery a clinical reality. Their perspective can be the difference between an academic pursuit and an impactful market-approved therapeutic,” A/Prof Lim said.

Associate Professor Rebecca Lim is an Affiliate Investigator with Stem Cells Australia.